Chronic cumulative exposure assessment PAΒΆ

This standard action is of type: Risks

In 2017 EFSA published a statement Risks for human health related to the presence of pyrrolizidine alkaloids in honey, tea, herbal infusions and food supplements, see EFSA (2017b). Occurrence data used in this opinion was published in 2015 in the external scientific report Occurrence of Pyrrolizidine Alkaloids in food, see Mulder et al. (2015). The occurrence data in tea and herbal infusions is linked to the Consumption of 6 different population groups of the DNFCS 2012-2016. An lower bound (LB) and upper bound (UB) chronic cumulative exposure assessment can be calculated for different PAs. One scenario is assuming equipotency, another scenario is using provisional RPFs (Merz and Schrenk (2016)).